Long‐term transgene expression can be mediated in the brain by adenoviral vectors when powerful neuron‐specific promoters are used
- 20 February 2003
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 5 (7) , 554-559
- https://doi.org/10.1002/jgm.381
Abstract
Background: Adenoviral (Ad) vectors are one of the most widely used tools for modelling gene therapy strategies. However, they have not been used in long‐term models of neurological disease, as the period of time for which they mediate strong transgene expression is limited and/or variable. In this study we investigated the longevity of transgene expression in the brain when the powerful neuron‐specific Ad‐synapsin (Sy)‐EGFP‐woodchuck hepatitis virus post‐transcriptional regulatory element (WPRE) vector cassette is used at titres that do not elicit an immune response.Methods: Adenoviral vectors expressing enhanced green fluorescent protein (EGFP) under the control of either the hCMV, hCMV‐WPRE, Sy or Sy‐WPRE promoter were constructed. These vectors were injected into the dentate gyrus region of hippocampus and transgene expression and immune cell infiltration assessed by fluorescence microscopy and immunocytochemical techniques, respectively.Results: The quantitative analysis of EGFP expression showed that there was no significant change in synapsin or synapsin‐WPRE driven transcription 9 months after injection when compared with expression levels obtained 3 days after injection. However, when the hCMV promoter or the hCMV‐WPRE promoter cassette drove transgene expression, there was a dramatic fall in expression levels and very little expression was seen 9 months post‐transfection.Conclusions: This study shows that non‐integrating vectors can be used to mediate powerful, long‐term episomal transgene expression in neurones. This work has important implications for neuronal gene therapy and is of relevance to studies investigating memory, behaviour and neuronal gene function. Copyright © 2003 John Wiley & Sons, Ltd.Keywords
This publication has 34 references indexed in Scilit:
- Towards Global and Long-Term Neurological Gene Therapy: Unexpected Transgene Dependent, High-Level, and Widespread Distribution of HSV-1 Thymidine Kinase throughout the CNSMolecular Therapy, 2001
- Inhibition of JNK by Overexpression of the JNK Binding Domain of JIP-1 Prevents Apoptosis in Sympathetic NeuronsPublished by Elsevier ,2001
- Acute Direct Adenoviral Vector Cytotoxicity and Chronic, but Not Acute, Inflammatory Responses Correlate with Decreased Vector-Mediated Transgene Expression in the BrainMolecular Therapy, 2001
- Strong Promoters Are the Key to Highly Efficient, Noninflammatory and Noncytotoxic Adenoviral-Mediated Transgene Delivery into the Brain in VivoMolecular Therapy, 2000
- Prolonged Transgene Expression Mediated by a Helper-Dependent Adenoviral Vector (hdAd) in the Central Nervous SystemMolecular Therapy, 2000
- Gene therapy in the CNSGene Therapy, 2000
- Efficient gene transfer and long-term expression in neurons using a recombinant adenovirus with a neuron-specific promoterGene Therapy, 1999
- Switching transgene expression in the brain using an adenoviral tetracycline-regulatable systemNature Biotechnology, 1998
- Neuron-specific Gene Expression of Synapsin IJournal of Biological Chemistry, 1996
- Viral Persistence in Neurons Explained by Lack of Major Histocompatibility Class I ExpressionScience, 1991